Foldable glued-IOL procedure successful

Article

The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.

The foldable glued-IOL technique provides satisfactory and safe visual outcomes, claims a paper in the latest issue of the Journal of Cataract and refractive Surgery.

Dr Amar Agarwal et al., Dr Agarwal's Eye Hospital and Eye Research Centre, Chennai, India, studied 208 eyes of 185 patients who received a primary glued foldable IOL for intraoperative capsular loss or subluxated lens or secondary glued foldable IOL for aphakia.

The exclusion criteria included preoperative glaucoma, aniridia, macular scar, traumatic subluxation, combined surgeries, incomplete operative medical records and a postoperative follow-up of less than six months. Among the outcome measures were intraoperative and postoperative complication rates, reoperation rate and visual outcomes were analysed.

Intraoperative complications presented were hyphaema, haptic breakage and deformed haptics in 0.4%, 0.4% and 0.9% of patients, respectively. There were early complications in 13.9% of eyes, including corneal oedema, epithelial defect and grade two anterior chamber reaction.

The late complications occurred in 18.7% of eyes and included optic capture, IOL decentration, haptic extrusion, subconjunctival haptic, macular oedema and pigment dispersion.

The group discovered that reoperation was required in 7.7% of eyes and haptic position was altered in eyes with IOL decentration. Corrected distance visual acuity was 20/40 or better in 38.9% of eyes and 20/60 or better in 48.5% of eyes. IOL decentration was caused by haptic-related issues.

For more details on the study please click here.

Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.